Ipsen obtains an exclusive license to develop, manufacture and commercialize a pre-clinical stage METTL3-inhibitor programme
CuraTeQ Biologics is on track for filing a second oncology biosimilar
Sandoz is committed to building on its leading generic and biosimilar oncology portfolio to further expand patient access while contributing to the sustainability of healthcare systems
The transactions resulted in a net cash inflow of Rs 183 crores for HCG in addition to the take-over of the labs and clinical research business
The foundation has been working closely with the Kidwai Memorial Institute of Oncology on several projects since 2001
The partnership is a significant step in delivering advanced cancer therapies to patients.
The appointments come as Andrew Paterson, who has spent 31 years with the company, prepares to retire
The approval is based on results from the pivotal Phase 3 KEYNOTE-905 trial
Karkinos’ model aims to close both gaps by combining World Health Organization-recommended HPV DNA testing with a digitally enabled continuum of care
The offer is being made through Harmony Row Acquisition Co., a wholly owned GSK subsidiary, and targets all outstanding Class A and Class B shares of Nuvalent
Subscribe To Our Newsletter & Stay Updated
